Recce Pharma Expands to Middle East
Recce Pharmaceuticals signs 10-year licensing deal for R327G in the Middle East, expanding its global reach. The deal aims to boost the company's presence in the region.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.